http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Securing Malaysia’s Borders from Covid-19: Legal Considerations to the Influx of Rohingya Migrants
Rusli Hazmi,Dremliuga Roman,Suhaili Wan,Farisha Nur Alia 이준국제법연구원 2021 Journal of East Asia and International Law Vol.14 No.1
On March 18, 2020, Malaysian Prime Minister Tan Sri Muhyiddin Yassin declared the nationwide enforcement of the Movement Control Order to curb the spread of COVID-19. In September 2020, Malaysia entered the third wave of the outbreak. Active cases rose from 60 to more than 13,000. The government’s Ops Benteng stops illegal migrants, who are at high risk of bringing COVID-19 into Malaysia. This includes illegal Rohingya migrants, who enter Malaysia to flee persecution in their home country, Myanmar. There are approximately 150,000 Rohingya migrants in Malaysia and more are expected. This article examines the main reason behind the influx of Rohingya illegal migrants and discusses whether the Malaysian government should tighten its borders to safeguard against COVID-19. The government must prioritise its own citizens over the Rohingyas; the responsibility of managing this humanitarian disaster should be shared with other nations, particularly those party to the United Nations Convention relating to the Status of Refugees 1951.
Syafawati Shamsahal Din,Siti Syariah Mamat,Noor Aisyah Ismail,Wan Noraziemah Wan Zainulddin,Zalina Zabidi,Farhana Yahya,Farah Hidayah Kamisan,Norhafizah Mohtarrudin,Fezah Othman,Zarizal Suhaili,Zainul 셀메드 세포교정의약학회 2012 TANG Vol.2 No.4
The present study aimed to determine the hepatoprotective activity of the chloroform extract of D. linearis leaves (CEDL) using the paracetamol (PCM)- and carbon tetrachloride (CCl4)-induced liver injury models in rats. The rats received dH2O (negative control), 200 mg/kg of silymarin (positive control) or CEDL (50, 250 and 500 mg/kg) orally once daily for 7 days and then were subjected to the hepatotoxic induction on the 7th day. The samples (i.e. blood and liver) were collected and underwent biochemical and microscopical analysis, respectively. From the data obtained, both inducers caused significant (p < 0.05) increase in the levels of AST and ALT when compared to the control group, which were significantly (p < 0.05) reduced by CEDL in a generally dose-dependent manner. These biochemical findings were supported by the histopathological analysis and histological scoring. In conclusion, CEDL possesses potential hepatoprotective activity, which could be associated with its flavonoid and tannin contents with the mechanisms of hepatoprotection linked to either its antioxidant or anti-inflammtory /immunomodulating activities. Further in-depth studies are required to identify the responsible bioactive compound.